Pre-commercial
Research payments
$14,672,866
Through program year 2023, $14,672,866 in research payments was reported against Pre-commercial, across 2,346 payments, paid by BioNTech SE.
- Paid by
- BioNTech SE
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $14,672,866 | 2,346 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Drew Weissman Philadelphia, PA Named on 363 payments
- Vicki Miller Pasadena, TX Named on 156 payments
- Douglas Denham San Antonio, TX Named on 145 payments
- Harvey Friedman Philadelphia, PA Named on 104 payments
- Devalingam Mahalingam Chicago, IL Named on 72 payments
- Corey Anderson Mesa, AZ Named on 65 payments
- William Smith New Orleans, LA Named on 63 payments
- Meredith McKean Nashville, TN Named on 56 payments
- Barbara Galligan Sacramento, CA Named on 53 payments
- John Rubino Raleigh, NC Named on 53 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.